From nuclease-based gene knock-in to prime editing – promising technologies of precision gene engineering
Gene and Genome Editing · 2022
DOI: 10.1016/j.ggedit.2022.100017 ↗Kurz gefasst
Fachartikel in der Zeitschrift Gene and Genome Editing, 2022. Verfasst von Tetsushi Sakuma. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 88 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Japan Society for the Promotion of Science.
Abstract (Originalsprache)
Gene knock-in can be defined as the introduction of precisely determined modifications, insertions, or replacements to the genome, which enables the generation of reporter cells, disease modeling and correction, humanization of animal cells and organisms, and so on. To date, gene knock-in systems have reached the fourth stage; i.e., the first, second, and third stages depend on unconstrained homologous recombination (HR)-mediated strategy, genome editing-assisted HR, and genome editing with various DNA double-strand break (DSB) repair pathways such as non-homologous end-joining and microhomology-mediated end-joining, respectively. Finally, in the fourth stage, DSB-free precision gene editors such as base editor and prime editor became available. These diversified strategies open up a new era of intentional editing of the genome, widely contributing to the functional genomics study.
Förderung
- Japan Society for the Promotion of Science
Zitieren
APA
Sakuma, T. (2022). From nuclease-based gene knock-in to prime editing – promising technologies of precision gene engineering. Gene and Genome Editing. https://doi.org/10.1016/j.ggedit.2022.100017
Vancouver
Sakuma T. From nuclease-based gene knock-in to prime editing – promising technologies of precision gene engineering. Gene and Genome Editing. 2022. doi:10.1016/j.ggedit.2022.100017
BibTeX
@article{Sakuma2022,
author = {Sakuma, Tetsushi},
title = {From nuclease-based gene knock-in to prime editing – promising technologies of precision gene engineering},
journal = {Gene and Genome Editing},
year = {2022},
doi = {10.1016/j.ggedit.2022.100017}
}
EUVIMED